Drug companies love the Orphan Drug Act. They say it encourages research into breakthrough therapies for people with rare disease. And sometimes that’s true. Lots of the time, though, the companies would’ve pursued the research anyhow. And those same companies have learned to game the Orphan Drug Act in a bunch of different ways, allowing them to jack up their prices for no good reason.
How could we fix the Orphan Drug Act? That’s the topic of this week’s Healthcare Triage.
Sources can be found in the posts Nick has written on the subject! Special thanks to him!